<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00271440</url>
  </required_header>
  <id_info>
    <org_study_id>R01-HD44004-2</org_study_id>
    <nct_id>NCT00271440</nct_id>
  </id_info>
  <brief_title>Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal</brief_title>
  <acronym>NNIPS-SFS</acronym>
  <official_title>Effect of Chlorhexidine Cleansing on Skin Flora of Newborns in Nepal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tribhuvan University, Nepal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Nepal Nutrition Intervention Project Sarlahi</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the reductions in skin flora of newborns after a
      single cleansing of the body with three concentrations of chlorhexidine (0.25%, 0.5%, 1.0%)
      and to examine the safety of skin cleansing in neonates in Nepal.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies in Malawi, Egypt, and Nepal suggest that neonatal skin cleansing with chlorhexidine
      solutions may reduce the risk of infection and mortality. Cleansing with 0.25% chlorhexidine
      in Nepal resulted in a 28% reduction in mortality among low birth weight infants, while there
      was no impact on infants of normal weight. The mechanism of action for this observed benefit
      is not clear. Chlorhexidine may remove pathogens from the skin of the newborn and/or prevent
      exposure to pathogens that may otherwise cause infection and lead to sepsis. The benefit of
      chlorhexidine cleansing may be extended with higher concentrations of chlorhexidine.

      Infants born at the Tribhuvan University Teaching Hospital in Katmandu, Nepal will be
      randomized to skin cleansing with chlorhexidine at one of three concentrations (0.25%, 0.50%,
      1.00%). Skin swabs will be collected before wiping, and two and twenty-four hours after
      wiping in order to compare levels of bacteria on the skin across the treatment groups. A
      small quantity of blood will be collected at 24 hours after wiping to determine the potential
      for absorption of chlorhexidine
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <primary_completion_date type="Actual">April 2006</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin flora reduction across treatment groups</measure>
    <time_frame>prior to wipe, 2hrs after, and 24hrs after</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum concentrations of chlorhexidine 24 hours after wipe</measure>
    <time_frame>24 hrs after wipe</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">286</enrollment>
  <condition>Bacterial Infection</condition>
  <arm_group>
    <arm_group_label>CHX 1.0%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1.0% CHX wiping</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHX 0.5%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.5% Chlorhexidine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CHX 0.25%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>chlorhexidine cleansing with pre-soaked pre-sealed wipe</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>skin cleansing with chlorhexidine (0.25%, 0.5%, 1%)</intervention_name>
    <arm_group_label>CHX 1.0%</arm_group_label>
    <arm_group_label>CHX 0.5%</arm_group_label>
    <arm_group_label>CHX 0.25%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  babies born at Tribhuvan University Teaching Hospital

          -  greater than 1500 grams

        Exclusion Criteria:

          -  less than 1500 grams

          -  requires major surgical procedure

          -  clinically evident skin infection

          -  generalized skin disease

          -  major congenital anomoly
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luke C Mullany, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tribhuvan University Teaching Hospital</name>
      <address>
        <city>Kathmandu</city>
        <country>Nepal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2005</study_first_submitted>
  <study_first_submitted_qc>December 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 2, 2006</study_first_posted>
  <last_update_submitted>April 2, 2010</last_update_submitted>
  <last_update_submitted_qc>April 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2010</last_update_posted>
  <keyword>chlorhexidine</keyword>
  <keyword>neonatal</keyword>
  <keyword>skin flora</keyword>
  <keyword>skin cleansing</keyword>
  <keyword>bacterial colonization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bacterial Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

